" class="no-js "lang="en-US"> Blackrock Neurotech - Medtech Alert
Saturday, September 13, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Blackrock Neurotech | Pharmtech Focus

Blackrock Neurotech

About Blackrock Neurotech

Blackrock Neurotech

Blackrock Neurotech’s mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. Blackrock’s precision electrode technology is at the core of many worldwide innovations in Brain-Computer Interfaces (BCI) and through neural signal processing and stimulation has enabled BCI Pioneers to walk, talk, see, hear, and feel again.

Related Story

Fundraising

 Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology | Pharmtech Focus

Blackrock Neurotech Closes $10M Financing Round To Advance Development Of Its World-Leading Brain-Computer Interface (BCI) Technology

May 20 2021

Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed […]